319 related articles for article (PubMed ID: 18952909)
41. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
Helbling PM; Saulnier DM; Brändli AW
Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
[TBL] [Abstract][Full Text] [Related]
42. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
[TBL] [Abstract][Full Text] [Related]
43. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
You C; Zhao K; Dammann P; Keyvani K; Kreitschmann-Andermahr I; Sure U; Zhu Y
J Cell Mol Med; 2017 Sep; 21(9):1848-1858. PubMed ID: 28371279
[TBL] [Abstract][Full Text] [Related]
44. EphB4 forward signalling regulates lymphatic valve development.
Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
[TBL] [Abstract][Full Text] [Related]
45. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
46. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
47. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C
Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666
[TBL] [Abstract][Full Text] [Related]
48. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Du E; Li X; He S; Li X; He S
Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
[TBL] [Abstract][Full Text] [Related]
49. Functional characterization of Klippel-Trenaunay syndrome gene AGGF1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis.
Chen D; Li L; Tu X; Yin Z; Wang Q
Hum Mol Genet; 2013 Mar; 22(5):963-76. PubMed ID: 23197652
[TBL] [Abstract][Full Text] [Related]
50. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
51. The role of Delta-like 4 ligand/Notch-ephrin-B2 cascade in the pathogenesis of preeclampsia by regulating functions of endothelial progenitor cell.
Liu X; Luo Q; Zheng Y; Liu X; Hu Y; Wang F; Zou L
Placenta; 2015 Sep; 36(9):1002-10. PubMed ID: 26212082
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development.
Chennakesava CS; Di Santo S; Ziemiecki A; Schneider H; Andres AC
Placenta; 2006; 27(9-10):959-67. PubMed ID: 16343615
[TBL] [Abstract][Full Text] [Related]
53. Notch4 reveals a novel mechanism regulating Notch signal transduction.
James AC; Szot JO; Iyer K; Major JA; Pursglove SE; Chapman G; Dunwoodie SL
Biochim Biophys Acta; 2014 Jul; 1843(7):1272-84. PubMed ID: 24667410
[TBL] [Abstract][Full Text] [Related]
54. Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.
Zhang XQ; Takakura N; Oike Y; Inada T; Gale NW; Yancopoulos GD; Suda T
Blood; 2001 Aug; 98(4):1028-37. PubMed ID: 11493448
[TBL] [Abstract][Full Text] [Related]
55. Substrate stiffness regulates arterial-venous differentiation of endothelial progenitor cells via the Ras/Mek pathway.
Xue C; Zhang T; Xie X; Zhang Q; Zhang S; Zhu B; Lin Y; Cai X
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1799-1808. PubMed ID: 28732675
[TBL] [Abstract][Full Text] [Related]
56. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
Kaenel P; Schwab C; Mülchi K; Wotzkow C; Andres AC
Int J Oncol; 2011 Jan; 38(1):151-60. PubMed ID: 21109936
[TBL] [Abstract][Full Text] [Related]
57. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium.
Masood R; Xia G; Smith DL; Scalia P; Still JG; Tulpule A; Gill PS
Blood; 2005 Feb; 105(3):1310-8. PubMed ID: 15471957
[TBL] [Abstract][Full Text] [Related]
58. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.
Gerety SS; Wang HU; Chen ZF; Anderson DJ
Mol Cell; 1999 Sep; 4(3):403-14. PubMed ID: 10518221
[TBL] [Abstract][Full Text] [Related]
59. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ
Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459
[TBL] [Abstract][Full Text] [Related]
60. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.
Murtomaki A; Uh MK; Choi YK; Kitajewski C; Borisenko V; Kitajewski J; Shawber CJ
Development; 2013 Jun; 140(11):2365-76. PubMed ID: 23615281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
